Cognitively engaging walking exercise and brain stimulation for older adults
Official title: Cognitively Engaging Walking Exercise and Neuromodulation to Enhance Brain Function in Older Adults
Run by University of Florida · NCT05830942 · Data updated 2026-11-12
This study is testing if combining brain stimulation with fun walking exercises can help older adults with mild to moderate cognitive decline improve their thinking and walking skills.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 65 Years and up |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | University of Florida Academic / other |
| Locations | 2 sites (Gainesville, Florida and 1 other locations) |
| Status | Recruiting |
| Started | April 15, 2024 |
| Main results expected | April 30, 2027 |
| Study ends | April 30, 2027 |
| Registry record updated | June 3, 2026 |
| Trial ID | NCT05830942 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are older adults aged 65 and above with mild to moderate cognitive decline who can walk independently.
✕Probably not a fit
Patients with major cognitive disorders or those on medications affecting neuroplasticity may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effects of combining cognitively engaging walking exercises with non-invasive electrical brain stimulation on cognitive and mobility functions in older adults. Participants will engage in complex walking tasks while receiving either active or sham transcranial direct current stimulation (tDCS) over a period of six weeks. The primary outcomes will assess improvements in executive function and walking abilities through standardized assessments. The trial aims to enroll up to 120 older adults with mild to moderate cognitive decline, conducted at two sites in Florida.
Why it matters
Potential benefit: If successful, this approach could enhance cognitive and mobility functions in older adults, potentially improving their quality of life.
How similar studies have gone: Other studies have shown promise in using tDCS for cognitive enhancement, but this specific combination of interventions is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 65+ * Objective executive function decline, based on standardized cognitive assessments. * Subjective cognitive decline, based on the question: "During the past 12 months, have you experienced confusion or memory loss that is happening more often or getting worse?" * Ability to walking independently for 6 minutes (use of cane permitted) Exclusion Criteria: * Major cognitive disorder that interferes with independence * Percentile score less than 10th percentile on standardized cognitive assessments * Medications that are thought to influence tDCS neuroplasticity. * Contraindications to tDCS or MRI.
Where it's running
-
University of Florida
Gainesville, Florida, United States Recruiting -
Brooks Rehabilitation
Jacksonville, Florida, United States Recruiting
Study contacts
- Principal investigator: David J Clark, ScD — University of Florida
- Study coordinator: David J Clark, ScD
- Email: davidclark@ufl.edu
- Phone: 352-376-1611
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Frailty Training for Emergency Nurses in Morocco
This trial tests whether a four-module training program helps Moroccan emergency nurses recognize and care for frail older adults in the ER.
-
New flutemetamol F18 formulation to see if it works as well as current for brain amyloid imaging
Researchers are testing a new flutemetamol F18 formulation (GE-287) to see if it identifies brain amyloid as accurately as the current formulation in people 50 and older who are undergoing amyloid PET scans for cognitive decline.
-
Zanubrutinib plus Lenalidomide for frail elderly with newly diagnosed PCNSL
This study tests whether a combination of zanubrutinib and lenalidomide can help frail elderly patients with newly diagnosed primary CNS lymphoma.
-
Longevity Metrics AI/ML Development Study
Researchers are testing AI models that score health screening tests and predict outcomes like life expectancy for adults, using ongoing follow-up data.
-
Immersive nature-based wellbeing program for older adults with cognitive impairment
A nature-inspired immersive virtual reality program is being tested to see if it can improve well-being and daily function for older adults with mild to moderate cognitive impairment.
-
Hesperidin for better thinking in overweight older adults
In adults aged 55–75 who are overweight, taking hesperidin or a placebo for 10 weeks will show whether the citrus flavonoid can improve thinking skills like memory, attention, and problem-solving.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.